| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TMSB4Y | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | ASB13 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | TLE1 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | SLC25A31 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | PLD6 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | AGBL3 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | PRKCB | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | PARP16 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | CARF | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | PNISR | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
